Overview
Altay Therapeutics, Inc., a San Carlos, CA-based biotechnology company developing novel small molecule inhibitors of transcription factors, closed a $37m Series A financing. The round was co-led by Sound Bioventures and HealthCap, with participation from new investors including Fountain Healthcare Partners, Biogen New Ventures, Pappas Capital, and Global BioAccess Fund....See more
Website
https://www.altaytherapeutics.com/Headquarters
San Carlos, CA
Upgrade to view team
View current team members and their roles
Access founders information
Request warm introductions
Funding Rounds (1)
$37.0M • Series A
Announced on 10/14/2026
Open Positions(0)
No open jobs posted for this organization yet.
Company Updates
No updates available yet.